BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 23686603)

  • 1. Formulary systems and pharmacy and therapeutics committees in the Western Pacific Region: exploring two Basel Statements.
    Penm J; Chaar B; Dechun J; Moles R
    Am J Health Syst Pharm; 2013 Jun; 70(11):967-79. PubMed ID: 23686603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validating a hospital medicines formulary survey in the Western Pacific Region--a global hospital pharmacy initiative based on the Basel Statements.
    Penm J; Chaar B; Moles R
    Res Social Adm Pharm; 2012; 8(4):298-308. PubMed ID: 22169173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hospital pharmacy services in the Pacific Island countries.
    Penm J; Chaar B; Moles R
    J Eval Clin Pract; 2015 Feb; 21(1):51-6. PubMed ID: 25041043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Literature review on the structure and operation of Pharmacy and Therapeutics Committees.
    Durán-García E; Santos-Ramos B; Puigventos-Latorre F; Ortega A
    Int J Clin Pharm; 2011 Jun; 33(3):475-83. PubMed ID: 21416393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing conflicts of interest in pharmacy and therapeutics committees: A proposal for multicentre formulary development.
    Friesen P; Caplan AL; Miller JE
    J Clin Pharm Ther; 2020 Apr; 45(2):249-255. PubMed ID: 31657022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activities, functions, and structure of pharmacy and therapeutics committees in large teaching hospitals.
    Mannebach MA; Ascione FJ; Gaither CA; Bagozzi RP; Cohen IA; Ryan ML
    Am J Health Syst Pharm; 1999 Apr; 56(7):622-8. PubMed ID: 10423208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing--2001.
    Pedersen CA; Schneider PJ; Santell JP
    Am J Health Syst Pharm; 2001 Dec; 58(23):2251-66. PubMed ID: 11763804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacy services that influence prescribing in the Western Pacific Region based on the FIP Basel Statements.
    Penm J; Chaar B; Moles R
    Int J Clin Pharm; 2015 Jun; 37(3):485-96. PubMed ID: 25733064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for success in creating an effective multihospital health-system pharmacy and therapeutics committee.
    Leonard MC; Thyagarajan R; Wilson AJ; Sekeres MA
    Am J Health Syst Pharm; 2018 Apr; 75(7):451-455. PubMed ID: 29572313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survey of formulary system policies and procedures.
    Rascati KL
    Am J Hosp Pharm; 1992 Jan; 49(1):100-3. PubMed ID: 1570847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational pharmacotherapy in The Netherlands: formulary management in Dutch hospitals.
    Fijn R; de Jong-van den Berg LT; Brouwers JR
    Pharm World Sci; 1999 Apr; 21(2):74-9. PubMed ID: 10380234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic substitution and formulary systems. American College of Physicians.
    Ann Intern Med; 1990 Jul; 113(2):160-3. PubMed ID: 2360752
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacists' influences on prescribing: validating a clinical pharmacy services survey in the Western Pacific Region.
    Penm J; Chaar B; Rose G; Moles R
    Res Social Adm Pharm; 2015; 11(1):63-73. PubMed ID: 25042568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical approach to grading evidence for formulary recommendations.
    Ansani NT; Fedutes-Henderson BA; Skledar SJ; Branch R; Sirio CA; Smitherman T; Weber RJ
    Am J Health Syst Pharm; 2005 Jul; 62(14):1498-501. PubMed ID: 15998932
    [No Abstract]   [Full Text] [Related]  

  • 15. Access to new cardiovascular therapies in Canadian hospitals: a national survey of the formulary process.
    Shalansky SJ; Virk R; Ackman M; Jackevicius C; Kertland H; Tsuyuki R; Humphries K;
    Can J Cardiol; 2003 Feb; 19(2):173-9. PubMed ID: 12601443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of adverse drug reaction data to drug choice decisions made by pharmacy and therapeutics committees. An Australian perspective.
    Weekes LM; Day RO
    Drug Saf; 1998 Mar; 18(3):153-9. PubMed ID: 9530535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the presentation of drug information to pharmacy and therapeutics committees for formulary decisions.
    Sterné SC; Uchida KM; Iteen SA
    Am J Health Syst Pharm; 1996 May; 53(10):1162-4. PubMed ID: 8734677
    [No Abstract]   [Full Text] [Related]  

  • 18. ASHP national survey of pharmacy practice in hospital settings: prescribing and transcribing--2004.
    Pedersen CA; Schneider PJ; Scheckelhoff DJ
    Am J Health Syst Pharm; 2005 Feb; 62(4):378-90. PubMed ID: 15745890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulary management.
    Scroccaro G
    Pharmacotherapy; 2000 Oct; 20(10 Pt 2):317S-321S. PubMed ID: 11034059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Priority setting in a hospital drug formulary: a qualitative case study and evaluation.
    Martin DK; Hollenberg D; MacRae S; Madden S; Singer P
    Health Policy; 2003 Dec; 66(3):295-303. PubMed ID: 14637013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.